Skip Navigation



JAC Advance Access published online on May 24, 2005
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dki173
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
56/1/97    most recent
dki173v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dryselius, R.
Right arrow Articles by Good, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dryselius, R.
Right arrow Articles by Good, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org
Received March 9, 2005
Revised April 13, 2005
Accepted April 19, 2005

Original article

Antimicrobial synergy between mRNA- and protein-level inhibitors

Rikard Dryselius 1*, Natalia Nekhotiaeva 1, and Liam Good 1

1 Center for Genomics and Bioinformatics, Karolinska Institutet, Berzelius väg 35, 171 77, Stockholm, Sweden

* To whom correspondence should be addressed.
Rikard Dryselius, E-mail: rikard.dryselius{at}cgb.ki.se


  Abstract

Background: The few available distinct classes of antimicrobials limits the scope for single and combination drug treatment of resistant infections.

Objective: To evaluate antimicrobial effectiveness from combinations of protein-specific drugs and mRNA-specific antisense inhibitors.

Methods: Interactions between conventional antimicrobial drugs and mRNA-specific translation inhibiting antisense peptide nucleic acids were assessed in Escherichia coli and Staphylococcus aureus cultures using pairwise combinations in a chequerboard arrangement. Fractional inhibitory concentration indices (FICIs) were calculated and grouped according to the functional relationship between the inhibitor targets. Antisense specificity controls included different antisense sequences targeting the same mRNA, as well as biochemical quantification of active protein expressed from the essential fabI gene and from the lacZ reporter gene after single and combined inhibitor treatment.

Results: FICIs were higher for inhibitor combinations with unrelated targets than for combinations with functionally related targets. Inhibitor combinations with shared genetic targets displayed the lowest FICIs, with several qualifying for the conservative definition of antimicrobial synergy (FICI ≤ 0.5). Furthermore, low FICIs arise as the hyperbolic dose-response curves for each separate inhibitor are maintained in combination.

Conclusion: Interactions between mRNA- and protein-level inhibitors with the same genetic target can be synergistic and may provide a strategy to improve antimicrobial efficacy, facilitate drug mechanism of action studies and aid the search for new antimicrobials.

Keywords: antimicrobial treatment; antisense; chequerboard; inhibitor combinations; PNA.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
N. Woodford, D. W. Wareham, and on behalf of the UK Antibacterial Antisense Study
Tackling antibiotic resistance: a dose of common antisense?
J. Antimicrob. Chemother., February 1, 2009; 63(2): 225 - 229.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
N. Nakashima, T. Tamura, and L. Good
Paired termini stabilize antisense RNAs and enhance conditional gene silencing in Escherichia coli
Nucleic Acids Res., November 6, 2006; 34(20): e138 - e138.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.